Dr. Robert Barclay, MD
Claim this profileRockford Gastroenterology Associates, Ltd.
Studies Irritable Bowel Syndrome
Studies Syndrome
1 reported clinical trial
1 drug studied
Affiliated Hospitals
More about Robert Barclay, MD
Clinical Trial Related16 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Robert Barclay, MD has experience with
- DDP733
Breakdown of trials Robert Barclay, MD has run
Irritable Bowel Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Robert Barclay, MD specialize in?
Robert Barclay, MD focuses on Irritable Bowel Syndrome and Syndrome. In particular, much of their work with Irritable Bowel Syndrome has involved treating patients, or patients who are undergoing treatment.
Is Robert Barclay, MD currently recruiting for clinical trials?
No, Robert Barclay, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Robert Barclay, MD has studied deeply?
Yes, Robert Barclay, MD has studied treatments such as DDP733.
What is the best way to schedule an appointment with Robert Barclay, MD?
Apply for one of the trials that Robert Barclay, MD is conducting.
What is the office address of Robert Barclay, MD?
The office of Robert Barclay, MD is located at: Rockford Gastroenterology Associates, Ltd., Rockford, Illinois 61107 United States. This is the address for their practice at the Rockford Gastroenterology Associates, Ltd..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.